Quercetin, green tea catechins, cocoa flavonoids, epicatechin, and marine polyphenols all look promising on paper for aging muscle. A new systematic review in GeroScience asked whether that promise holds up in randomized controlled trials of adults 55 and older. The answer is more sober than the supplement aisle would like: strength moved in two of five trials, and muscle mass barely moved in any way you can pin on the polyphenol itself.
The Question Behind the Hype
Sarcopenia, the progressive age-related loss of muscle mass and function, is tied to mitochondrial dysfunction, oxidative stress, and chronic low-grade inflammation. Polyphenols are plant compounds with antioxidant and anti-inflammatory activity in cell and animal studies, so they have become natural candidates for slowing that decline.
Plausible mechanisms are not the same as human results, though. The review, by Diaz-Vallejo, Gonzalez-Correa, and Padilla (2026), set out to test that gap. It followed PRISMA 2020 and Cochrane guidance, was registered on PROSPERO (CRD420251183284), and included only randomized controlled trials in adults aged 55 or older. Outcomes were skeletal muscle mass, strength, or physical function.
What the Review Actually Found
The search turned up six trials. Five reported outcome data and entered the synthesis. The sixth is an ongoing registered protocol with no results yet. The completed trials tested:
- Quercetin
- Epicatechin-rich extracts
- Tea catechins
- Cocoa flavonoids
- Marine-derived polyphenols
Trial durations ran from 4 to 24 weeks. That is short for a condition that develops over years or decades.
Strength: A Partial Win
Muscle strength improved significantly on between-group comparison in two of the five completed trials. That is a real signal, but it is a minority of the evidence. The abstract does not say which compounds produced those two positive results, so it would be wrong to name a winner. Anyone hoping for a clean ranking of quercetin versus cocoa versus tea catechins will not find one here.
Muscle Mass: Murky
The mass results were inconsistent:
- One trial showed a significant group-by-time interaction, but the intervention combined polyphenols with amino acids and exercise. It is hard to credit the polyphenol when protein building blocks and training were in the mix.
- Another trial showed an attenuated loss of muscle without a significant between-group difference. This is encouraging in direction but does not meet the bar for a demonstrated effect.
- The remaining trials showed null effects or results that were less clearly attributable to the polyphenol.
For anyone hoping a capsule will add lean mass, this is the sobering part.
Function and Balance
Functional and balance outcomes improved in two of the three trials that measured them. This is a modestly positive note, since practical function matters more to older adults than a scan number. But with so few trials, it is hard to say how reliable the finding is.
Why the Evidence Is Thin
The authors say a formal meta-analysis was not feasible, because there were too few trials and they differed too much clinically. Instead they tabulated effect estimates and uncertainty and did a structured direction-of-effect synthesis. That is an appropriate approach for a small, messy literature.
The heterogeneity is considerable:
- Different compounds. Quercetin, catechins, cocoa flavanols, and marine polyphenols are chemically and pharmacologically distinct.
- Different designs. Some trials tested a polyphenol alone and others combined it with exercise or amino acids.
- Different durations. Four weeks and 24 weeks are very different windows for detecting changes in muscle.
- Different populations. Many participants did not have confirmed sarcopenia, which leaves little room to improve.
The review concludes that effects are "biologically plausible but currently inconsistent" and that the evidence is too small, heterogeneous, and methodologically limited to support therapeutic recommendations.
Who Might Care, and What to Do With This
This review does not show polyphenols are useless. It shows we don't yet know. A few cautious takeaways:
- Exercise and protein remain the proven foundation. The one positive mass result came from a combination that included exercise and amino acids. Supplements are not a substitute for resistance training and adequate protein.
- Polyphenol-rich foods are a reasonable baseline. Tea, cocoa, and produce carry other health benefits, and nothing here argues against them. But this review tested supplements, not diet, so it cannot say that food sources build muscle.
- Don't expect large effects. Even the best-case reading is a modest strength benefit in some trials.
- People with diagnosed sarcopenia are the target group. The authors call for trials in this population, which means current evidence in healthy older adults may understate or overstate what would happen in those who most need help.
- Talk to a clinician first. Concentrated extracts can interact with medications, and supplement quality and dosing vary widely.
What Comes Next
The authors call for larger, standardized randomized trials in people with confirmed sarcopenia. They also want direct neuromuscular assessment, which would help separate effects on muscle tissue from effects on nerve signaling, motivation, or inflammation. The ongoing registered trial is one to watch.
The Bottom Line
Polyphenols make mechanistic sense for aging muscle, but the human data are early, mixed, and hard to compare. Strength gains appeared in two of five trials, mass was inconsistent, and the small, short, varied studies cannot support a recommendation. For now, treat these supplements as an unproven add-on rather than a muscle-rebuilding strategy, and keep your effort on resistance training and protein.